Two Sigma Advisers’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.41M | Buy |
553,100
+448,200
| +427% | +$7.62M | 0.02% | 528 |
|
|
2025
Q1 | $2.05M | Buy |
104,900
+85,900
| +452% | +$1.68M | ﹤0.01% | 1149 |
|
|
2024
Q4 | $471K | Buy |
19,000
+8,300
| +78% | +$206K | ﹤0.01% | 1799 |
|
|
2024
Q3 | $262K | Sell |
10,700
-32,100
| -75% | -$786K | ﹤0.01% | 1968 |
|
|
2024
Q2 | $1M | Sell |
42,800
-105,400
| -71% | -$2.47M | ﹤0.01% | 1552 |
|
|
2024
Q1 | $4.9M | Buy |
+148,200
| New | +$4.9M | 0.01% | 787 |
|
|
2023
Q3 | – | Sell |
-8,500
| Closed | -$271K | – | 2394 |
|
|
2023
Q2 | $271K | Sell |
8,500
-16,400
| -66% | -$524K | ﹤0.01% | 2011 |
|
|
2023
Q1 | $762K | Sell |
24,900
-21,500
| -46% | -$658K | ﹤0.01% | 1765 |
|
|
2022
Q4 | $1.81M | Sell |
46,400
-54,600
| -54% | -$2.14M | 0.01% | 1294 |
|
|
2022
Q3 | $4.81M | Buy |
101,000
+50,600
| +100% | +$2.41M | 0.01% | 752 |
|
|
2022
Q2 | $1.95M | Buy |
+50,400
| New | +$1.95M | 0.01% | 1232 |
|
|
2022
Q1 | – | Sell |
-13,700
| Closed | -$1.09M | – | 2737 |
|
|
2021
Q4 | $1.09M | Sell |
13,700
-51,700
| -79% | -$4.12M | ﹤0.01% | 1524 |
|
|
2021
Q3 | $5.69M | Buy |
65,400
+13,100
| +25% | +$1.14M | 0.01% | 726 |
|
|
2021
Q2 | $6.73M | Buy |
+52,300
| New | +$6.73M | 0.02% | 725 |
|